Hexem Bio

developing a scalable stem cell rejuvenation therapy that restores aged hematopoietic stem cells, enabling them to produce healthier blood and immune cells. Its lead program aims to improve bone marrow transplant outcomes for blood cancer patients, with broader potential across age-related diseases and immune decline.